'Gadonanotubes' greatly outperform existing MRI contrast agents
...es more effective than the best in clinical use.
The new agents -- dubbed gadonanotubes
-- use the same highly toxic metal, gadolinium, that is given to more than ...e existing methods of attaching disease-specific antibodies and peptides to gadonanotubes
so they can be targeted to cancerous tumors and other diseased cells.